Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isa Mambetsariev

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Oncotarget|July 26, 2018
Heuristic value-based framework for lung cancer decision-makingIsa Mambetsariev, Rebecca Pharaon, Arin Nam, et al.
Cancer Immunology, Immunotherapy : CII|August 6, 2024
Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case seriesRamya Muddasani, Neel Talwar, Isa Mambetsariev, et al.
American Journal of Clinical Oncology|February 12, 2019
Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung AdenocarcinomaRohan Gupta, Idoroenyi Amanam, Syed Rahmanuddin, et al.
Cell Reports. Medicine|February 4, 2023
Integration of artificial intelligence in lung cancer: Rise of the machineColton Ladbury, Arya Amini, Ameish Govindarajan, et al.
Journal of Clinical Medicine|March 10, 2022
Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung CancerIsa Mambetsariev, Leonidas Arvanitis, Jeremy Fricke, et al.
Clinical Lung Cancer|February 28, 2021
Therapeutic Potential of Olaparib in Combination With Pembrolizumab in a Young Patient With a Maternally Inherited BRCA2 Germline Variant: A Research ReportThomas Waddington, Isa Mambetsariev, Rebecca Pharaon, et al.
Journal of Thoracic Disease|November 4, 2020
Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survivalIdoroenyi Amanam, Isa Mambetsariev, Rohan Gupta, et al.
Cureus|August 11, 2021
Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung CancerAngel R Baroz, Isa Mambetsariev, Jeremy Fricke, et al.
Brain Sciences|July 29, 2023
Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation StatusBihong T Chen, Taihao Jin, Ningrong Ye, et al.
Clinical Lung Cancer|August 14, 2023
Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case SeriesJeremy Fricke, Joshua Wang, Natalie Gallego, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Oncotarget|July 26, 2018
Heuristic value-based framework for lung cancer decision-makingIsa Mambetsariev, Rebecca Pharaon, Arin Nam, et al.
Cancer Immunology, Immunotherapy : CII|August 6, 2024
Clinical features associated with immune checkpoint inhibitor nephritis: a single-center clinical case seriesRamya Muddasani, Neel Talwar, Isa Mambetsariev, et al.
American Journal of Clinical Oncology|February 12, 2019
Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung AdenocarcinomaRohan Gupta, Idoroenyi Amanam, Syed Rahmanuddin, et al.
Cell Reports. Medicine|February 4, 2023
Integration of artificial intelligence in lung cancer: Rise of the machineColton Ladbury, Arya Amini, Ameish Govindarajan, et al.
Journal of Clinical Medicine|March 10, 2022
Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung CancerIsa Mambetsariev, Leonidas Arvanitis, Jeremy Fricke, et al.
Clinical Lung Cancer|February 28, 2021
Therapeutic Potential of Olaparib in Combination With Pembrolizumab in a Young Patient With a Maternally Inherited BRCA2 Germline Variant: A Research ReportThomas Waddington, Isa Mambetsariev, Rebecca Pharaon, et al.
Journal of Thoracic Disease|November 4, 2020
Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survivalIdoroenyi Amanam, Isa Mambetsariev, Rohan Gupta, et al.
Cureus|August 11, 2021
Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung CancerAngel R Baroz, Isa Mambetsariev, Jeremy Fricke, et al.
Brain Sciences|July 29, 2023
Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation StatusBihong T Chen, Taihao Jin, Ningrong Ye, et al.
Clinical Lung Cancer|August 14, 2023
Selpercatinib and Pralsetinib Induced Chylous Ascites in RET-Rearranged Lung Adenocarcinoma: A Case SeriesJeremy Fricke, Joshua Wang, Natalie Gallego, et al.
Pageof 8